CytomX Therapeutics Inc (CTMX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 946k | 23.5M | 24.72M | 26.38M | 26.61M | 41.46M | 25.12M | 33.43M |
営業利益 | -28.69M | -5.65M | -3.35M | 3.12M | -606k | 11.66M | -8.45M | 4.11M |
税引前収入 | -27.95M | -3.31M | -1.09M | 5.82M | 1.91M | 13.84M | -6.48M | 5.8M |
純利益 | -27.95M | -3.31M | -1.09M | 2.99M | 837k | 13.79M | -6.53M | 5.74M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -28.68M | -5.64M | -3.38M | 3.12M | -597k | 11.65M | -8.45M | 4.1M |
EBITDA | -28.08M | -5.06M | -2.74M | 3.61M | -120k | 12.12M | -7.99M | 4.54M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 15.04M | 71.62M | 59.5M | 57.49M | 100.36M | 69.57M | 53.16M | 101.21M |
営業利益 | -59.59M | -46.26M | -77.87M | -110.9M | -48.61M | -83.78M | -101.34M | -6.48M |
税引前収入 | -58.92M | -43.61M | -70.3M | -102.67M | -46.8M | -83.61M | -99.32M | 3.32M |
純利益 | -58.9M | -43.1M | -84.6M | -102.24M | -32.89M | -83.61M | -99.32M | -569k |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.614 | -1.12 | -1.877 | -2.246 | -0.682 | -1.279 | -1.5 | -0.008 |
EBIT | -59.59M | -46.26M | -77.87M | -111.03M | -48.63M | -83.86M | -101M | -6.51M |
EBITDA | -57.85M | -44.61M | -75.99M | -108.25M | -46.03M | -81.08M | -98.89M | -4.31M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約